BostonGene forms JV for precision medicine in Japan with NEC and JIP
The new Tokyo-based JV company will use BostonGene’s high-complexity molecular technology and advanced biocomputational algorithms to expedite the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Aug 23
The new Tokyo-based JV company will use BostonGene’s high-complexity molecular technology and advanced biocomputational algorithms to expedite the…
23 Aug 23
The clinical study, conducted by researchers from major academic centres and urology practices across the US, evaluated the…
23 Aug 23
GeneseeqPrime and GeneseeqPrime HRD are indicated for solid tumour genomic profiling while Hemasalus DNA/Hemarna RNA is approved for…
18 Aug 23
In collaboration with DataRobot, FOXO will utilise the predictive AI’s capabilities and high-throughput automation to predict factors related…
18 Aug 23
The cobas® connection modules (CCM) sample conveyors system has been extended with newly developed elevator and overhead conveyor…
14 Aug 23
HebeCell is primarily engaged in developing universal and cost-effective NK cell therapeutics based on its proprietary 3D pluripotent…
11 Aug 23
The partnership will launch a non-small cell lung cancer (NSCLC) assay in the US, developed based on ChromaCode’s…
10 Aug 23
The combined company will operate as Sunbird Bio and focuses on advancing clinical-stage platforms with established potential to…
08 Aug 23
The Alinity h-series system includes an integrated slide maker and stainer Alinity hs, and an automated haematology analyser…
04 Aug 23
Under the partnership, Tufts Medicine’s patients and providers are expected to get better access to testing, shorter wait…